AwardedAwarded 26 October 2026
Ono type DX Breast Recurrence Score Test
Leeds Teaching Hospitals NHS Trust · NHS and health
In brief
Leeds Teaching Hospitals NHS Trust awarded healthcare work to Exact Sciences UK, Ltd. on 26 October 2026.
The notice gives a value of £405,000 excluding VAT.
The contract runs for 2 years, starting 1 July 2026.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of
chemotherapy in this patient population and is uniquely available from the current supplier on
the global market.
Who won
| Winner | Value | Dates |
|---|---|---|
| Exact Sciences UK, Ltd. (SME) | £337,500 | Awarded 26 October 2026 |
| Exact Sciences UK, Ltd. (SME) | £337,500 | Awarded 26 October 2026 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Contract award notice · notice 2e5c2542-f55d-49f6-90bb-79ebbca96bf6-919090
- Contract award notice · notice 8c60ade2-e308-4405-8dd6-657c132b1cb3-919091
About the buyer
Leeds Teaching Hospitals NHS TrustLast 12 months
Procurements
239Awards
185Suppliers it has used most for healthcare
- Exact Sciences UK, Ltd.1 contract
- Harris-Jones Medical LTD(TA Gynevision)1 contract
- Light Medical Ltd1 contract
- Local Care Direct Limited1 contract
- The Condition Management Company1 contract
Similar open tenders
All open healthcare tenders- £4.84mframework ceiling
- £2.52mestimated
- £1.25mestimated
- £288kestimated
- £120kestimated
From notice 2e5c2542-f55d-49f6-90bb-79ebbca96bf6-919090 on Contracts Finder, first published 26 October 2026, last updated 26 October 2026. We last checked for changes on 26 October 2026.